FDA Investigator: Sean R. Marcsisin

- Sean R. Marcsisin first started conducting FDA inspections in 2016, with the last inspection in 2024. Over that time, Sean R. Marcsisin has conducted 83 inspections at 68 companies across 70 sites.

Get Sean Marcsisin's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Genzyme Corporation, Framingham | 2024

Out-of-stock
Sean R. Marcsisin
Human Drugs Form 483

FDA 483 Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, Bedford | 2024

Out-of-stock
Sean R. Marcsisin
Human Drugs Form 483

FDA 483 Cipla Limited, Raigad | 2024

Out-of-stock
Sean R. Marcsisin
Human Drugs Form 483

FDA 483 ZYDUS LIFESCIENCES LIMITED, Matoda | 2024

Out-of-stock
Sean R. Marcsisin
Human Drugs Form 483

FDA 483 EyePoint Pharmaceuticals, Inc., Watertown | 2024

Out-of-stock
Sean R. Marcsisin
Human Drugs Form 483

FDA 483 PS-Connections, LLC, North Kingstown | 2024

Out-of-stock
Sean R. Marcsisin
Human Drugs Form 483

FDA 483 NextPharma OY, Tampere | 2022

Out-of-stock
Sean R. Marcsisin
Human Drug Form 483

FDA 483 Lumene Oy, Espoo | 2022

Out-of-stock
Sean R. Marcsisin
Human Drug Form 483

Co-Investigators (45)